Item 9 Labs Corp. — Form D
Item 9 Labs Corp. of PHOENIX, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-30. The offering totals $8.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-12-30
- Form: D
- Accession: 0001554795-20-000340
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.5M
- Amount sold: $2.5M
- Remaining: $6.0M
- Minimum investment: $85K
- Investors: 21
- Date of first sale: 2020-11-13
- Security types: equity
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-384703
Issuer
- Name: Item 9 Labs Corp.
- CIK: 0001500123
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 2727 NORTH 3RD STREET, PHOENIX, AZ, 85004
- Phone: 833-867-6337
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Ron Miller | Director | TORONTO, A6 |
| Ronald Miller | Director | Las Vegas, NV |
| Robert Mikkelsen | Executive Officer | Phoenix, AZ |
| Andrew Bowden | Director | Phoenix, AZ |
| Andrew Bowden | Executive Officer | Phoenix, AZ |
| Ronald L Miller, Jr. | Director | Phoenix, AZ |
| Michael L Keskey | Director | Phoenix, AZ |
| Jeffrey L Rassas | Director | Phoenix, AZ |
| Jeffrey L Rassas | Executive Officer | Phoenix, AZ |
| Christopher L Wolven | Executive Officer | Phoenix, AZ |
| Douglas L Bowden | Director | Phoenix, AZ |
| Bryce L Skalla | Director | Phoenix, AZ |
| Bryce L Skalla | Executive Officer | Phoenix, AZ |
| Sara Gullickson | Director | Phoenix, AZ |
| Sara Gullickson | Executive Officer | Phoenix, AZ |
| Jeffrey Rassas | Director | Phoenix, AZ |
| Jeffrey Rassas | Executive Officer | Phoenix, AZ |
| Bryce Skalla | Director | Phoenix, AZ |
| Bryce Skalla | Executive Officer | Phoenix, AZ |
| Robert Mikkelson | Executive Officer | Phoenix, AZ |
| DANIEL J COHEN | Director | SCOTTSDALE, AZ |
| DANIEL J COHEN | Executive Officer | SCOTTSDALE, AZ |
| JESSICA SMITH | Executive Officer | SCOTTSDALE, AZ |
| RONALD J MILLER | Director | SCOTTSDALE, AZ |
Other filings by this issuer (6)
More